» Articles » PMID: 28962616

Statistical Prediction of Immunity to Placental Malaria Based on Multi-assay Antibody Data for Malarial Antigens

Overview
Journal Malar J
Publisher Biomed Central
Specialty Tropical Medicine
Date 2017 Oct 1
PMID 28962616
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Plasmodium falciparum infections are especially severe in pregnant women because infected erythrocytes (IE) express VAR2CSA, a ligand that binds to placental trophoblasts, causing IE to accumulate in the placenta. Resulting inflammation and pathology increases a woman's risk of anemia, miscarriage, premature deliveries, and having low birthweight (LBW) babies. Antibodies (Ab) to VAR2CSA reduce placental parasitaemia and improve pregnancy outcomes. Currently, no single assay is able to predict if a woman has adequate immunity to prevent placental malaria (PM). This study measured Ab levels to 28 malarial antigens and used the data to develop statistical models for predicting if a woman has sufficient immunity to prevent PM.

Methods: Archival plasma samples from 1377 women were screened in a bead-based multiplex assay for Ab to 17 VAR2CSA-associated antigens (full length VAR2CSA (FV2), DBL 1-6 of the FCR3, 3D7 and 7G8 lines, ID1-ID2a (FCR3 and 3D7) and 11 antigens that have been reported to be associated with immunity to P. falciparum (AMA-1, CSP, EBA-175, LSA1, MSP1, MSP2, MSP3, MSP11, Pf41, Pf70 and RESA)). Ab levels along with clinical variables (age, gravidity) were used in the following seven statistical approaches: logistic regression full model, logistic regression reduced model, recursive partitioning, random forests, linear discriminant analysis, quadratic discriminant analysis, and support vector machine.

Results: The best and simplest model proved to be the logistic regression reduced model. AMA-1, MSP2, EBA-175, Pf41, and MSP11 were found to be the top five most important predictors for the PM status based on overall prediction performance.

Conclusions: Not surprising, significant differences were observed between PM positive (PM+) and PM negative (PM-) groups for Ab levels to the majority of malaria antigens. Individually though, these malarial antigens did not achieve reasonably high performances in terms of predicting the PM status. Utilizing multiple antigens in predictive models considerably improved discrimination power compared to individual assays. Among seven different classifiers considered, the reduced logistic regression model produces the best overall predictive performance.

Citing Articles

The Development, Fine Specificity, and Importance of High-Avidity Antibodies to VAR2CSA in Pregnant Cameroonian Women Living in Yaoundé, an Urban City.

Vanda K, Bobbili N, Matsunaga M, Chen J, Salanti A, Leke R Front Immunol. 2021; 12:610108.

PMID: 33717094 PMC: 7953046. DOI: 10.3389/fimmu.2021.610108.


Pregnancy-specific malarial immunity and risk of malaria in pregnancy and adverse birth outcomes: a systematic review.

Cutts J, Agius P, Lin Z, Powell R, Moore K, Draper B BMC Med. 2020; 18(1):14.

PMID: 31941488 PMC: 6964062. DOI: 10.1186/s12916-019-1467-6.


Association of Antibodies to VAR2CSA and Merozoite Antigens with Pregnancy Outcomes in Women Living in Yaoundé, Cameroon.

Lloyd Y, Fang R, Bobbili N, Vanda K, Ngati E, Sanchez-Quintero M Infect Immun. 2018; 86(9).

PMID: 29986889 PMC: 6105894. DOI: 10.1128/IAI.00166-18.

References
1.
Clausen T, Christoffersen S, Dahlback M, Langkilde A, Jensen K, Resende M . Structural and functional insight into how the Plasmodium falciparum VAR2CSA protein mediates binding to chondroitin sulfate A in placental malaria. J Biol Chem. 2012; 287(28):23332-45. PMC: 3390611. DOI: 10.1074/jbc.M112.348839. View

2.
Achur R, Valiyaveettil M, Naik R, Ockenhouse C, Zhou A, Megnekou R . Gravidity-dependent production of antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to placental chondroitin sulfate proteoglycan during pregnancy. Infect Immun. 2001; 69(12):7487-92. PMC: 98838. DOI: 10.1128/IAI.69.12.7487-7492.2001. View

3.
Magistrado P, Minja D, Doritchamou J, Ndam N, John D, Schmiegelow C . High efficacy of anti DBL4ɛ-VAR2CSA antibodies in inhibition of CSA-binding Plasmodium falciparum-infected erythrocytes from pregnant women. Vaccine. 2010; 29(3):437-43. DOI: 10.1016/j.vaccine.2010.10.080. View

4.
Duffy P, Fried M . Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns. Infect Immun. 2003; 71(11):6620-3. PMC: 219546. DOI: 10.1128/IAI.71.11.6620-6623.2003. View

5.
Pihur V, Datta S, Datta S . Weighted rank aggregation of cluster validation measures: a Monte Carlo cross-entropy approach. Bioinformatics. 2007; 23(13):1607-15. DOI: 10.1093/bioinformatics/btm158. View